NL153516B - Werkwijze ter bereiding van 1,4-methano- en -ethanotetrahydronaftyloxypropanolen met beta-adrenergische receptoren blokkerende werking; werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen. - Google Patents

Werkwijze ter bereiding van 1,4-methano- en -ethanotetrahydronaftyloxypropanolen met beta-adrenergische receptoren blokkerende werking; werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.

Info

Publication number
NL153516B
NL153516B NL727214106A NL7214106A NL153516B NL 153516 B NL153516 B NL 153516B NL 727214106 A NL727214106 A NL 727214106A NL 7214106 A NL7214106 A NL 7214106A NL 153516 B NL153516 B NL 153516B
Authority
NL
Netherlands
Prior art keywords
preparation
ethanotetrahydronaphtyloxy
propanols
methano
preparations
Prior art date
Application number
NL727214106A
Other languages
English (en)
Dutch (nl)
Other versions
NL7214106A (da
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NL7214106A publication Critical patent/NL7214106A/xx
Publication of NL153516B publication Critical patent/NL153516B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/38—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL727214106A 1971-10-21 1972-10-18 Werkwijze ter bereiding van 1,4-methano- en -ethanotetrahydronaftyloxypropanolen met beta-adrenergische receptoren blokkerende werking; werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen. NL153516B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3012471 1971-10-21

Publications (2)

Publication Number Publication Date
NL7214106A NL7214106A (da) 1973-04-25
NL153516B true NL153516B (nl) 1977-06-15

Family

ID=11229158

Family Applications (1)

Application Number Title Priority Date Filing Date
NL727214106A NL153516B (nl) 1971-10-21 1972-10-18 Werkwijze ter bereiding van 1,4-methano- en -ethanotetrahydronaftyloxypropanolen met beta-adrenergische receptoren blokkerende werking; werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.

Country Status (21)

Country Link
JP (1) JPS515379B2 (da)
AT (1) AT318563B (da)
AU (1) AU471732B2 (da)
BE (1) BE790188R (da)
CA (1) CA992983A (da)
CH (1) CH565741A5 (da)
CS (1) CS161064B2 (da)
DE (1) DE2251095C3 (da)
DK (1) DK135576B (da)
FR (1) FR2157897B2 (da)
GB (1) GB1351557A (da)
HK (1) HK9377A (da)
HU (1) HU165185B (da)
IL (1) IL40610A (da)
KE (1) KE2693A (da)
MY (1) MY7700158A (da)
NL (1) NL153516B (da)
NO (1) NO130643C (da)
SE (1) SE389103B (da)
SU (1) SU496722A3 (da)
ZA (1) ZA727459B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436860A (en) * 1972-12-18 1976-05-26 Syntex Inc 5,8-dihydro-5,8-methanonaphthalene cardiovascular agents
JPS52120690A (en) * 1976-04-02 1977-10-11 Fujitsu Ltd Radiation semi-conductor device

Also Published As

Publication number Publication date
KE2693A (en) 1977-02-11
NO130643C (da) 1975-01-15
DE2251095C3 (de) 1976-01-02
IL40610A (en) 1975-04-25
NL7214106A (da) 1973-04-25
JPS515379B2 (da) 1976-02-19
GB1351557A (en) 1974-05-01
FR2157897A2 (da) 1973-06-08
DK135576C (da) 1977-10-31
AU4707772A (en) 1974-04-04
SE389103B (sv) 1976-10-25
DE2251095B2 (de) 1975-05-07
NO130643B (da) 1974-10-07
ZA727459B (en) 1974-05-29
CA992983A (en) 1976-07-13
AU471732B2 (en) 1976-04-29
IL40610A0 (en) 1972-12-29
CS161064B2 (da) 1975-05-04
DE2251095A1 (de) 1973-05-10
DK135576B (da) 1977-05-23
HU165185B (da) 1974-07-27
SU496722A3 (ru) 1975-12-25
CH565741A5 (da) 1975-08-29
AT318563B (de) 1974-10-25
BE790188R (fr) 1973-04-17
HK9377A (en) 1977-02-25
FR2157897B2 (da) 1975-06-20
MY7700158A (en) 1977-12-31
JPS4849750A (da) 1973-07-13

Similar Documents

Publication Publication Date Title
NL930015I2 (nl) Werkwijze ter bereiding van nonapepide-aminederivaten, en farmaceutische preparaten met ovulatie-opwekkende werking daaruit.
NL159654B (nl) Werkwijze ter bereiding van diaminoverbindingen met fungicide werking en werkwijze ter bereiding van preparaten, die deze diaminoverbindingen bevatten.
IT1053975B (it) Procedimento per la preparazione di derivati dello immidazo 2.1 b tiazolo prodotto ottenuto e relativo impiego
NL160150C (nl) Werkwijze ter bereiding van 3-acyloxy-2-fenyl-1h- -indeen-1-on-derivaten met herbicide- en acaricide werking, alsmede herbicide- en acaricidepreparaten die deze verbindingen als actieve component bevatten.
NL150680B (nl) Werkwijze ter bereiding van farmaceutische preparaten.
NL167151C (nl) Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.
NL7706646A (nl) Werkwijze ter bereiding van diuretisch werkzame farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, als- mede werkwijze ter bereiding van diuretisch werk- zame verbindingen.
NL7501794A (nl) Werkwijze ter bereiding van een geneesmiddel met (beta)-adrenolytische werking, de door toepassing van deze werkwijze verkregen geneesmiddelen, alsmede een werkwijze ter bereiding van (beta)-adrenolytisch werkzame 1-fenoxy 2-hydroxy 3-alkylaminopropaan- derivaten.
NL150101B (nl) Werkwijze voor het bereiden van 3-aryloxy-2-hydroxypropylaminen met (beta)-adrenergisch blokkerende werking; werkwijze ter bereiding van (beta)-adrenergisch blokkerende farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen.
FI49503C (fi) Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi.
NL160485C (nl) Werkwijze ter bereiding van farmaceutische preparaten met anti-inflammatoire, analgetische en anti-pyretische wer- king, alsmede door toepassing van deze werkwijze verkregen voorwerpen.
NL139233B (nl) Werkwijze ter bereiding van verbindingen met coronairvatverwijdende werking, alsmede werkwijze ter bereiding van farmaceutische preparaten en gevormde preparaten.
NL161434B (nl) Werkwijze voor de bereiding van farmaceutische prepara- ten met alfa-sympathicolytische werking, gevormde pre- paraten en werkwijze voor de bereiding van aminoalkyl- tetrahydro 1-ketonaftaleenderivaten.
NL160275C (nl) Werkwijze ter bereiding van farmaceutische preparaten met anti-leukemische en anti-inflammatoire werking, de door toepassing daarvan verkregen gevormde voortbrengselen en werkwijze ter bereiding van anti-leukemisch en anti-inflam- matoir werkzame verbindingen.
NL157012B (nl) Werkwijze voor de bereiding van farmaceutische preparaten met anti-inflammatoire werking, aldus verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van anti-inflammatoir werkzame heterocyclische verbindingen.
NL177823C (nl) Werkwijze ter bereiding van ureum- en thioureumverbindingen met insecticide werking alsmede van insecticide preparaten.
NL148037B (nl) Werkwijze voor de bereiding van farmaceutische preparaten en de door toepassing daarvan vervaardigde voorwerpen, alsmede werkwijze ter bereiding van anti-inflammatoir, analgetisch, antipyretisch en antipruritisch werkzame verbindingen.
NL7512107A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten met antiinflammatoire werking, de door toepassing daarvan verkregen voorwerpen, alsmede werkwijze ter bereiding van verbindingen met anti-inflammatoire werking.
NL153516B (nl) Werkwijze ter bereiding van 1,4-methano- en -ethanotetrahydronaftyloxypropanolen met beta-adrenergische receptoren blokkerende werking; werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.
AR199826A1 (es) Procedimiento para la preparacion de oxazoles 2,4,5-trisustituidos
NL166267C (nl) Werkwijze ter bereiding van farmaceutische preparaten, de onder toepassing daarvan verkregen gevormde voort- brengselen, alsmede werkwijze ter bereiding van 6,7-methyleen-20-spirox-4-en-3-onderivaten met aldoste- ron remmende werking.
NL151080B (nl) Werkwijze ter bereiding van 10-aminoalkyl-11-oxo-10,11-dihydrobenzo(b,f) (1,4)oxazepinen, werkwijze ter bereiding van farmaceutische preparaten met antidepressieve werking die deze verbindingen als werkzaam bestanddeel bevatten, en gevormde preparaten.
NL157305B (nl) Werkwijze ter bereiding van derivaten van 1-fenoxy-2-hydroxy-3-aminopropaan met beta-adrenergisch blokkerende werking; werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.
NL175063C (nl) Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL7413959A (nl) Werkwijze ter bereiding van biocide heterocy- clische verbindingen en werkwijze ter bereiding van biocide preparaten.